Clinical Trial

Evaluation of the Clinical Efficacy and Mechanisms of Cord Plasma Eye Drops in the Treatment of Neuropathic Corneal Pain

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to investigate the efficacy and work of action of cord plasma eye drops in the treatment of neuropathic corneal pain (NCP). The main question it aims to answer if the cord plasma eye drops are effective for the treatment of NCP through its neurotrophic and anti-neuroinflammatory effects.
Trial Details
NCT Number NCT07566806
Lead Sponsor Singapore Eye Research Institute
Conditions Neuropathic Pain, Corneal Disease
Enrollment 20 participants
Start Date 2023-09-16
Primary Completion 2026-09-15 (estimated)
Study Completion 2027-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-05